Detalles de la búsqueda
1.
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
Lancet
; 397(10273): 499-509, 2021 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33549194
2.
A multiple testing procedure for multi-dimensional pairwise comparisons with application to gene expression studies.
BMC Bioinformatics
; 17: 104, 2016 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26917217
3.
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial.
Lancet HIV
; 11(6): e369-e379, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38734015
4.
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
Clin Drug Investig
; 43(9): 681-690, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676612
5.
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study.
Hepatol Commun
; 7(3): e0031, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36790337
6.
Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine.
J Acquir Immune Defic Syndr
; 91(1): 68-72, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35972855
7.
Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial.
Lancet HIV
; 8(6): e324-e333, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34000227
8.
Daptomycin for Pediatric Gram-Positive Acute Hematogenous Osteomyelitis.
Pediatr Infect Dis J
; 39(9): 814-823, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32639465
9.
Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia.
Pediatr Infect Dis J
; 37(9): 893-900, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29406465
10.
Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials.
Lancet Gastroenterol Hepatol
; 2(11): 814-823, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28802814
11.
Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials.
Lancet Gastroenterol Hepatol
; 2(11): 805-813, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28802816
Resultados
1 -
11
de 11
1
Próxima >
>>